📍Notre équipe Innovation & Développement a exploré BIG 2025 pour suivre les tendances et développer des solutions innovantes, comme le système Euroject®, visant à simplifier les soins et repenser les standards industriels. eu1.hubs.ly/H0nm0RJ0

🌍 Unither s’engage site par site ! Pour la Semaine Européenne du Développement Durable, découvrez nos actions RSE locales : réduction de l’impact, mobilisation des équipes, partenariats locaux et amélioration continue en santé, sécurité et énergie. #RSE #DéveloppementDurable

💉Join our Euroject® team at Booth 50 during the Parenteral Drug Association event in Vienna, Austria 21-22 october and discover how our pre-filled, single-dose BFS devices are set to transform vaccine and biologic delivery. Let's connect! eu1.hubs.ly/H0nqKtb0

🎙️ Découvrez l’épisode 3 du podcast InnoSphère ! Avec Rémi du Chalard, fondateur d’Artha France, la start-up qui a mis au point Artha, un dispositif unique au monde aidant les personnes déficientes visuelles à percevoir leur environnement. 🔔 eu1.hubs.ly/H0nGbHJ0

💉 Meet us at DCVMN Annual General Meeting – Bali, Indonesia | 29–31 October Our Euroject® team will be present at Booth S3 to discuss how our pre-filled, single-dose Blow-Fill-Seal technology is reshaping the way vaccines and biologics are delivered. eu1.hubs.ly/H0nHlkR0

💉Missed our Euroject®: From Formulation to Market webinar? Watch the replay to see how Blow-Fill-Seal (BFS) technology is transforming the injectable journey eu1.hubs.ly/H0nzMP-0 #Euroject #BFS #Injectables #Vaccines

#news We develop advanced ENT liquid delivery systems focused on patient safety and easy administration. Our customizable nasal, buccal, and ear sprays deliver precise dosing to support better adherence across diverse patient needs. 👉Learn more: eu1.hubs.ly/H0nRcxp0

À l’occasion de la Journée mondiale du don d’organes, nous célébrons la générosité qui apporte un nouvel espoir aux patients. Dans l’ép 2 de InnoSphère, Sophie Momège revient sur les innovations en greffe de cornée et sur l’impact de la solidarité. 🎧 eu1.hubs.ly/H0nS6L90

🌏 Join our team at leading November events driving pharmaceutical innovation. Connect with us: 📍 3-5 nov – Bio-Europe | Vienna, Austria 📍 5-6 nov – Vaccine World Asia | Bangkok, Thailand 📍 24-25 nov – euroPLX | Berlin, Germany 📩 eu1.hubs.ly/H0nQzVl0

Great energy from our team at the DCVMN Annual Meeting in Bali, where we discussed how BFS technology and Euroject® can help bring affordable, ready-to-use injectable solutions to more people worldwide. Next stop ➡️ Vaccine World Asia, Bangkok (Nov 5–6) 🇹🇭

#services Every product deserves the optimal form for patients, markets, and manufacturing goals. We transform molecules into launch-ready solutions, partnering from concept to industrial scale to define the best dosage form. 💡eu1.hubs.ly/H0pjRBx0

📣We’re currently at the Vaccine World Asia Congress in Bangkok! Our Business Development Marlish Ratnakumar and our CSO Alexandre Fontayne are on-site at booth #2 — meet them to learn more about Euroject®, our prefilled unidose solution designed for vaccines.

📣We’ll be at the China International Medical Expo in Taizhou (第十六届中国（泰州）国际医药博览会), from November 28 to 30. Let's connect and see how we can move forward together. #BFS #China #Innovation #Collaboration

#event 📍We will be at BioFIT on December 2–3, booth#D15 in Strasbourg! With the event’s focus on biotech innovation, it’s the ideal place to showcase Euroject®, our ready-to-use device designed to simplify and secure vaccine administration. Let's connect!

🎙️ Découvrez comment dans l’ép 3 du podcast InnoSphère ! Avec Yahya El Mir, fondateur de Ziwig, la biotech qui a mis au point l’Endotest, un dispositif innovant permettant de diagnostiquer l’endométriose rapidement, de manière non invasive et fiable. eu1.hubs.ly/H0q7M8Z0

#News We are pleased to announce our partnership with SeaBeLife Biotech to co-develop and manufacture the ophthalmic formulation of the SBL03 drug candidate, targeting geographic atrophy and dry AMD. 👉 Read the full press release: eu1.hubs.ly/H0qhnC50

Carragelose creates a protective barrier on the nasal and throat mucosa, preventing viruses from attaching. A simple solution that helps prevent respiratory infections or reduce their duration. 👉 Have a project in mind? Contact us! eu1.hubs.ly/H0qj9t-0

🎉 The entire Unither Pharmaceuticals team wishes you a wonderful holiday season! This year, we advanced key strategic projects: A new isolator in Bordeaux - Ophthalmic products Expansion of the Gannat site Acquisition of the Carragelose® portfolio A partnership with ONCOVITA

#event 📣 We’ll be attending PFS & Injectable Drug Devices Europe, from January 13 to 15 in London (UK). Let’s connect and see how we can move forward together. eu1.hubs.ly/H0qvhX50 #Injectables #DrugDelivery #Innovation

From all of us at Unither Pharmaceuticals, we warmly wish our clients, partners, and collaborators a happy and fulfilling 2026! 🎉 Thank you for your trust and collaboration. We look forward to sharing another year of growth, innovation, and success together.